BioCentury
ARTICLE | Company News

CoPharma licenses RC.552 from Corixa

January 17, 2001 8:00 AM UTC

CoPharma (Hopkinton, Mass.) obtained an exclusive license in territories including the U.S., Europe, and Japan to develop and commercialize RC.552, an aminoalkyl glucosaminide 4-phosphate, to treat or...